INT236559

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.65
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

lipid binding (Cd36) transport (Cd36) mitochondrion (Cd36)
cell adhesion (Cd36) Golgi apparatus (Cd36) plasma membrane (Cd36)
Cd36 (Mus musculus)
Pain Link Frequency Relevance Heat
tolerance 21 5.00 Very Low Very Low Very Low
agonist 11 5.00 Very Low Very Low Very Low
aspirin 3 5.00 Very Low Very Low Very Low
anesthesia 3 5.00 Very Low Very Low Very Low
isoflurane 3 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
Eae 2 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
dexamethasone 1 5.00 Very Low Very Low Very Low
ischemia 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 33 81.84 Quite High
Hypertriglyceridemia 12 59.44 Quite High
Dyslipidemia /

Combined Dyslipidemia

14 50.00 Quite Low
Increased Venous Pressure Under Development 22 47.84 Quite Low
Diabetes Mellitus 16 42.56 Quite Low
Metabolic Syndrome 8 42.08 Quite Low
Obesity 35 29.32 Quite Low
Hepatotoxicity 3 14.16 Low Low
Impaired Glucose Tolerance 19 5.00 Very Low Very Low Very Low
Insulin Resistance 13 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The effect on CD36 was cyclo-oxygenase dependent, whereas the effect on ATP-binding cassette protein A1 was blocked by an inhibitor of protein kinase A (downstream from adenylyl cyclase) (Rubic et al 2004).


Regulation (effect) of CD36
1) Confidence 0.42 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2605342 Disease Relevance 0.65 Pain Relevance 0
target genes involved in triglycerides (TG) synthesis such as lipoprotein lipase (Lpl), phosphoenolpyruvate carboxykinase (PEPCK) and CD36 was significantly upregulated in ?
Regulation (target) of CD36
2) Confidence 0.29 Published 2008 Journal PLoS Genetics Section Body Doc Link PMC2432036 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox